The WHO declared the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern on Sunday, May 17. [1] The PHEIC statement carried a sentence the WHO repeats when an outbreak crosses a border but does not call for travel restrictions: no country should close borders to citizens of affected countries. [1] On Monday afternoon, May 18, the U.S. Centers for Disease Control and Prevention invoked a Title 42 order barring entry to non-U.S. citizens who had been in the DRC, Uganda, or South Sudan within the previous 21 days, for 30 days. [2][3] By Wednesday night, the order had not been withdrawn, modified, or publicly defended in writing by the agency that signed it.
The paper's May 20 brief on WHO saying no country should close borders and CDC closing them Monday treated the contradiction as Tuesday's main artifact. The May 20 lead on the cartridge that tested for the wrong Ebola framed the outbreak as institutional failure with a measurable gap. Three days after the order, the silence on the contradiction is itself the document.
The order's signature is the gap with a name. The Title 42 order was signed by Dr. Jay Bhattacharya, identified as "Senior Official Carrying out the Delegable Duties of the Director" — the same official whose pre-pandemic writing argued against U.S. travel restrictions and lockdowns. [4] The order's own text concedes Ebola is not transmitted by asymptomatic travelers and that the restriction applies to non-U.S. citizens only, with U.S. citizens carrying the same exposure risk exempted by category. [4] Céline Gounder's Monday analysis observed the order "explains why it won't work." [4]
The Infectious Diseases Society of America posted its statement Monday. [5] IDSA CEO Jeanne Marrazzo, MD, MPH: "Public health policies that single out non-U.S. citizens won't prevent viruses from crossing our borders. Diseases don't recognize passports." [5] Africa CDC followed Tuesday with the most direct pushback. Director General Dr. Jean Kaseya: "Generalised travel restrictions and border closures are not the solution to outbreaks. The fastest path to protecting all countries in the world is to aggressively support outbreak control at the source." [6] The State Department's May 19 update confirmed the U.S. interagency was implementing the order through CBP and consular operations. [7]
The contradiction has two halves. The institutional half: WHO has not formally objected; the BMJ took the WHO statement and the CDC order as parallel facts without naming the gap. [3] PHEIC is a coordination instrument, not a treaty; the International Health Regulations make travel-restriction recommendations advisory. The clinical half is harder. Bundibugyo has no approved vaccine and no approved therapeutic. [8] Ervebo, Inmazeb, and Ebanga are licensed for Zaire strain only. CDC has named the entry restriction; it has not named whether the U.S. is committing antibody, isolation, or PPE shipments at the scale Africa CDC says it needs.
The PHEIC's working denominator is the order's most defensible argument. The BMJ count Monday: 336 suspected cases and 87 deaths in DRC, two confirmed cases and one death in Uganda, $500,000 from WHO's contingency fund. [3] CIDRAP added that the cluster traced to a nurse whose symptoms began April 24 and that cartridges calibrated for the wrong strain produced three weeks of negative tests in which open-casket funerals continued. [8] The denominator justifies caution. The order is a border closure. The cartridge gap is the operational lead.
Africa CDC's statement said the order risks "diverting movement toward informal and unmonitored routes — potentially increasing public health risks rather than reducing them." [6] CDC has not published a counter-argument. WHO has not published a counter-argument to CDC. The Title 42 instrument has stood for three days against a PHEIC instrument from the same week and the agencies have not spoken to each other in public.
The institutional question is whether the contradiction stays buried inside the two documents, or whether either agency files an amendment, a defense, or a withdrawal before Memorial Day. The clinical question — antibody supply, cartridge procurement, ring vaccination — is the underlying one. The Wednesday read is that the public-health calendar is moving and the institutional calendar is not.
-- NORA WHITFIELD, Chicago